Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Non-Invasive Measures of Distal Lung Disease in Asthmatics

This study has been completed.
Information provided by:
Teva Branded Pharmaceutical Products, R&D Inc. Identifier:
First received: November 4, 2005
Last updated: March 31, 2008
Last verified: March 2008

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

Condition Intervention Phase
Drug: QVAR
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Teva Branded Pharmaceutical Products, R&D Inc.:

Primary Outcome Measures:
  • High resolution Cat Scans

Estimated Enrollment: 34
Study Start Date: September 2005
Study Completion Date: September 2007
Detailed Description:

The study consists of 3 phases. There are 7 study visits.


Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 18-65 years old
  • Currently using SABA prn or a low-to-moderate persistent asthma

Exclusion Criteria:

  • Tobacco use within 1 year or >= 5 pack years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00250341

United States, California
Los Angeles, California, United States, 90095
Sponsors and Collaborators
Teva Branded Pharmaceutical Products, R&D Inc.
Principal Investigator: Michelle Zeidler, MD University of California, Los Angeles
  More Information

No publications provided Identifier: NCT00250341     History of Changes
Other Study ID Numbers: IXR-403-4-196
Study First Received: November 4, 2005
Last Updated: March 31, 2008
Health Authority: United States: Institutional Review Board processed this record on February 25, 2015